Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Doull (CCCCardiffCCardiff, United Kingdom), C. Course (Cardiff, United Kingdom), R. Hanks (Cardiff, United Kingdom), S. Moat (Cardiff, United Kingdom). Newborn Screening for Cystic Fibrosis in Wales over 20 years. Changes in incidence dependent on screening protocol. 4628

Member's Comments

No comment yet.

Related content which might interest you: Newborn screening for Cystic Fibrosis over 20 years and the identification of affected not detected infants. Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Newborn screening for cystic fibrosis in Spain Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Lung Cancer Prevalence after 4 years of screening in a COPD/Emphysema centered screening program Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 A review of Lung Transplantation for Cystic Fibrosis in Ireland in 2017. Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ? Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Cardiorespiratory Fitness in an adult Norwegian Cystic Fibrosis Population Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017 Year: 2017 Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis? Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 Contamination during 4-5 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST) Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Evidence incidence of cystic fibrosis: A 30-year study in Krasnoyarsk, Russia Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Changes in the Lung Clearance Index outside 15% are clinically relevant in children with cystic fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST) Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings Year: 2018 Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Respiratory rate in infants with Cystic Fibrosis and healthy controls throughout the first year of life. Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Stable lung function is maintained over 2 years in newborn screened (NBS) CF infants Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 The PELICAN (Prematurity's Effect on the Lungs In Children and Adults Network) ERS Clinical Research Collaboration: understanding the impact of preterm birth on lung health throughout life Source: Eur Respir J, 57 (4) 2004387; 10.1183/13993003.04387-2020 Year: 2021 Lung clearance index in young children with atypical CF Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016